top of page


In addition to our Functional Lab testing, Vis Clinic has access to a full range of conventional lab tests using a variety of laboratories. Labs are drawn on site. We provide customized panels to fit the needs of our providers and patients.


Male and Female Hormone Replacement Panel
Advanced Lipid and Cardiometabolic
And Many Others...
Routine Chemistries and Blood Count
Thyroid Panel Complete
Viral Antibody Profiles
Inflammation Panels

Boston Heart

Boston Heart offers novel diagnostics that drive reports with color coded test results, interpretations and clinical treatment considerations that help characterize risk, develop insight and communicate more reflectively with patients. Specializing in a wide range of laboratory techniques, including gas chromatography, gel electrophoresis, genetic testing, general chemistry, immunoassay, and high performance liquid chromatography.

Cleveland Heart

Cleveland HeartLab offers innovative, scientifically proven, and medically relevant biomarkers that are predictive of cardiovascular risk. Their novel biomarker technologies are offered through CAP-accredited and CLIA-certified clinical referenced laboratories. They also run a research and development laboratory where next-generation cardiovascular disease biomarkers are being developed for use through clinical laboratories. This valuable pipeline of tests is part of an exclusive intellectual property portfolio that targets large, under-addressed markets.

Quest Diagnostics

Quest Diagnostics is one of the world's leading providers of diagnostic information services.  They offer a test menu that is industry leading in breadth and innovation which ranges from routine biological tests to complex and specialized molecular and gene-based testing as well as anatomic pathology

Vibrant America

Vibrant America is a leading science and technology company delivering life-transforming laboratory services. Vibrant’s vision is to enable symptom-based diagnostics and prognostics for Autoimmune disease and other chronic diseases using an integrated micro-array platform that would enable multiplex testing at an affordable cost.

bottom of page